Cancer cells are known to have an increased rate of glycolysis, often referred to as the Warburg Effect. They rely heavily on glucose for energy and biosynthesis. 2-DG exploits this dependency by entering the cells and disrupting their energy production. This can slow down or inhibit the growth of cancer cells, making 2-DG a potential therapeutic agent.
